Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Vaxchora in Children 2 to <18 Years
NCT03220737Phase 4Completed
- Sponsor
- Bavarian Nordic
- Start
- Jul 2017
- Primary completion
- Sep 2019
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of cholera vaccine, live, oral in cholera, sponsored by Bavarian Nordic. Started Jul 2017; status: completed.
02
Drugs
cholera vaccine, live, oral
03
Conditions
cholera
Beyond the preview
Go deeper on NCT03220737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03220737.